CAS 33342-05-1
:Gliquidone
Description:
Gliquidone is an oral hypoglycemic agent belonging to the class of sulfonylureas, primarily used in the management of type 2 diabetes mellitus. It functions by stimulating insulin secretion from the pancreatic beta cells, thereby lowering blood glucose levels. Gliquidone is characterized by its chemical structure, which includes a sulfonylurea moiety, contributing to its pharmacological activity. The substance is typically administered in tablet form and is known for its moderate efficacy in glycemic control. Its pharmacokinetics involve absorption in the gastrointestinal tract, with peak plasma concentrations occurring within a few hours post-administration. Gliquidone is metabolized in the liver, and its metabolites are excreted primarily through the urine. Common side effects may include hypoglycemia, gastrointestinal disturbances, and allergic reactions. As with other sulfonylureas, it is essential for patients to monitor their blood glucose levels regularly and maintain a balanced diet and exercise regimen to optimize treatment outcomes. Caution is advised in patients with renal or hepatic impairment, as these conditions may affect the drug's metabolism and clearance.
Formula:C27H33N3O6S
InChI:InChI=1S/C27H33N3O6S/c1-27(2)23-14-11-20(36-3)17-22(23)24(31)30(25(27)32)16-15-18-9-12-21(13-10-18)37(34,35)29-26(33)28-19-7-5-4-6-8-19/h9-14,17,19H,4-8,15-16H2,1-3H3,(H2,28,29,33)
InChI key:InChIKey=LLJFMFZYVVLQKT-UHFFFAOYSA-N
SMILES:CC1(C)C=2C(C(=O)N(CCC3=CC=C(S(NC(NC4CCCCC4)=O)(=O)=O)C=C3)C1=O)=CC(OC)=CC2
Synonyms:- 1-Cyclohexyl-3-[4-[2-(7-methoxy-4,4-dimethyl-1,3-dioxo-1,2,3,4-tetrahydroisoquinolin-2-yl)ethyl]benzenesulfonyl]urea
- 1-Cyclohexyl-3-[4-[2-(7-methoxy-4,4-dimethyl-1,3-dioxoisoquinolin-2-yl)ethyl]phenyl]sulfonylurea
- 1-Cyclohexyl-3-[[p-[2-(3,4-dihydro-7-methoxy-4,4-dimethyl-1,3-dioxo-2(1H)-isoquinoyl)ethyl]phenyl]sulfonyl]urea
- Ar 3-Ardf 26
- Ar-Df 26
- Ardf 26Se
- Beglynor
- Glichidon
- Gliquidona
- Gliquidone
- Glurenorm
- N-[(Cyclohexylamino)carbonyl]-4-[2-(3,4-dihydro-7-methoxy-4,4-dimethyl-1,3-dioxo-2(1H)-isoquinolinyl)ethyl]benzenesulfonamide
- TangShenPing
- TangShiPing
- Zinc 01482077
- Zinc 1482077
- See more synonyms
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 14 products.
Gliquidone
CAS:Formula:C27H33N3O6SPurity:>98.0%(T)(HPLC)Color and Shape:White to Almost white powder to crystalMolecular weight:527.641-cyclohexyl-3-({4-[2-(7-methoxy-4,4-dimethyl-1,3-dioxo-1,2,3,4-tetrahydroisoquinolin-2-yl)ethyl]benzene}sulfonyl)urea
CAS:Formula:C27H33N3O6SPurity:99%Color and Shape:SolidMolecular weight:527.6324Gliquidone
CAS:<p>Gliquidone (AR-DF 26) is a potent, second-generation sulfonylurea with antihyperglycemic activity.</p>Formula:C27H33N3O6SPurity:98.92% - 99.93%Color and Shape:SolidMolecular weight:527.63N-(Cyclohexylcarbamoyl)-4-(2-(7-Methoxy-4,4-Dimethyl-1,3-Dioxo-3,4-Dihydroisoquinolin-2(1H)-Yl)Ethyl)Benzenesulfonamide
CAS:<p>N-(Cyclohexylcarbamoyl)-4-(2-(7-Methoxy-4,4-Dimethyl-1,3-Dioxo-3,4-Dihydroisoquinolin-2(1H)-Yl)Ethyl)Benzenesulfonamide</p>Purity:98%Molecular weight:527.63g/molGliquidone
CAS:Formula:C27H33N3O6SPurity:≥ 98.0%Color and Shape:White to off-white or pale yellow crystalline powderMolecular weight:527.63Gliquidone-d6
CAS:Formula:C27H27D6N3O6SColor and Shape:White To Off-White SolidMolecular weight:533.67Gliquidone
CAS:Controlled Product<p>Applications Gliquidone is an anti diabetic agent used in the treatment of hypoglycemia which leads to an increased risk in diabetic cardiovascular disease. Also used in the treatment diabetic nephropathy.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Tan, Z. et al.: Chinese Med. J., 127, 1298 (2014); Ke, J, et al.: J. Endocrinol., 220, 129 (2014);<br></p>Formula:C27H33N3O6SColor and Shape:NeatMolecular weight:527.633-Cyclohexyl-1-[4-[2-(7-methoxy -4,4-dimethyl-1,3-dioxo-isoquinolin -2-yl)ethyl]phenyl]sulfonyl-urea
CAS:<p>3-Cyclohexyl-1-[4-[2-(7-methoxy -4,4-dimethyl-1,3-dioxo-isoquinolin -2-yl)ethyl]phenyl]sulfonyl-urea is a drug that inhibits the enzyme DPPIV, which breaks down the incretin hormone glucagon-like peptide (GLP)-1. It may be used to treat diabetes by regulating blood glucose levels. This drug has been shown to reduce postprandial blood glucose levels in patients with type 2 diabetes. 3CYCSU is also capable of reducing body weight and food intake in mice. The mechanism of action of this drug is not fully understood, but it appears to have an effect on the cytosolic calcium ion concentration and may reduce inflammatory responses in cells. 3CYCSU is a promising potential treatment for infectious diseases such as Hepatitis C virus (HCV).</p>Formula:C27H33N3O6SColor and Shape:PowderMolecular weight:527.63 g/molGliquidone
CAS:GliquidoneFormula:C27H33N3O6SPurity:99.7%Color and Shape:WhiteMolecular weight:527.20901












